Townsend Asset Management’s Quest Diagnostics DGX Stock Holding History

Townsend Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Hold	1,198	–	–	0.08%	120
2025 Q4	$208K	Hold	1,198	–	–	0.07%	120
2025 Q3	$228K	Hold	1,198	–	–	0.08%	114
2025 Q2	$215K	Hold	1,198	–	–	0.08%	116
2025 Q1	$203K	Buy	+1,198	New	+$197K	0.08%	116
2022 Q4	–	Sell	-1,974	Closed	-$242K	–	202
2022 Q3	$242K	Hold	1,974	–	–	0.14%	117
2022 Q2	$263K	Hold	1,974	–	–	0.14%	119
2022 Q1	$270K	Hold	1,974	–	–	0.13%	119
2021 Q4	$342K	Hold	1,974	–	–	0.16%	99
2021 Q3	$287K	Hold	1,974	–	–	0.15%	114
2021 Q2	$261K	Hold	1,974	–	–	0.14%	122
2021 Q1	$253K	Hold	1,974	–	–	0.16%	118
2020 Q4	$235K	Hold	1,974	–	–	0.16%	120
2020 Q3	$226K	Hold	1,974	–	–	0.18%	118
2020 Q2	$225K	Buy	+1,974	New	+$209K	0.18%	115
2020 Q1	–	Sell	-1,974	Closed	-$211K	–	181
2019 Q4	$211K	Buy	+1,974	New	+$206K	0.17%	128

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Townsend Asset Management's DGX Position: Q1 2026 in Review

Townsend Asset Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,198 shares worth $235K. The position accounts for 0.08% of the portfolio, ranked #120.

Townsend Asset Management first reported a position in DGX in Q4 2019 and has held it in 16 quarters since. The position peaked at $342K in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Townsend Asset Management held 1,198 shares of Quest Diagnostics worth $235K as of Q1 2026.
Townsend Asset Management left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.08% of Townsend Asset Management's portfolio in Q1 2026, its #120 holding.
Townsend Asset Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 16 quarters since.
Townsend Asset Management's Quest Diagnostics position peaked at $342K in Q4 2021.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Townsend Asset Management's 13F filing for Q1 2026, filed 6 May 2026.